Ingevity EV/EBIT NGVT

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2017.

Today, Oct 23, 2026: 16.8×
10-year median: 9.8×
Against its 10-year history: 85th; percentile: 0 is its lowest day, 100 its highest
10-year range: 3.0× to 20.6×
Peer median: 16.3×

Ingevity's EV/EBIT is 16.8× as of Oct 23, 2026.

That is above its ten-year median of 9.8×, higher than on 85% of days in the last ten years.

Over that time it ranged from 3.0× in Oct 2024 to 20.6× in Sep 2025.

The median for 10 chemicals stocks of a similar size is 16.3×.

EV/EBIT over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	16.8×	9.4×	18.1×
2025	14.5×	3.6×	20.6×
2024	3.7×	3.0×	7.3×
2023	7.3×	6.4×	9.8×
2022	8.1×	6.4×	8.7×
2021	7.1×	7.1×	11.0×
2020	10.9×	5.6×	11.8×
2019	12.1×	11.7×	18.3×
2018	14.1×	13.5×	20.3×
2017	17.1×	13.3×	18.9×

Against its peers

Companies in Chemicals nearest Ingevity's size, closest first, today.

Company	EV/EBIT
NGVTIngevity	16.8×
IOSPInnospec	12.0×
ROGRogers	16.3×
FULFuller H B	10.7×
WDFCWD 40	24.6×
AVNTAvient	14.6×
CBTCabot	8.9×
CRONCronos	n/m
CSWCSW Industrials	26.0×
BCPCBalchem	25.9×
HXLHexcel	30.4×
Peer median	16.3×

Where Ingevity ranks

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Ingevity

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.